SG11201912890SA - Dissolving film for delivery of a clostridial derivative - Google Patents
Dissolving film for delivery of a clostridial derivativeInfo
- Publication number
- SG11201912890SA SG11201912890SA SG11201912890SA SG11201912890SA SG11201912890SA SG 11201912890S A SG11201912890S A SG 11201912890SA SG 11201912890S A SG11201912890S A SG 11201912890SA SG 11201912890S A SG11201912890S A SG 11201912890SA SG 11201912890S A SG11201912890S A SG 11201912890SA
- Authority
- SG
- Singapore
- Prior art keywords
- delivery
- dissolving film
- clostridial derivative
- clostridial
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762527212P | 2017-06-30 | 2017-06-30 | |
PCT/US2018/039964 WO2019006098A1 (en) | 2017-06-30 | 2018-06-28 | SOLUBLE FILM FOR THE ADMINISTRATION OF A CLOSTRIDIAL DERIVATIVE |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201912890SA true SG11201912890SA (en) | 2020-01-30 |
Family
ID=62976271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201912890SA SG11201912890SA (en) | 2017-06-30 | 2018-06-28 | Dissolving film for delivery of a clostridial derivative |
Country Status (14)
Country | Link |
---|---|
US (2) | US20190000935A1 (es) |
EP (2) | EP3644960A1 (es) |
JP (1) | JP2020526506A (es) |
KR (1) | KR20200024250A (es) |
CN (1) | CN110913838A (es) |
AU (1) | AU2018290925A1 (es) |
BR (1) | BR112019028080A2 (es) |
CA (1) | CA3066951A1 (es) |
CL (1) | CL2019003873A1 (es) |
IL (1) | IL271278A (es) |
MX (1) | MX2019015451A (es) |
RU (1) | RU2020101929A (es) |
SG (1) | SG11201912890SA (es) |
WO (1) | WO2019006098A1 (es) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN142428B (es) * | 1974-07-05 | 1977-07-09 | Schering Ag | |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
DE10252726B4 (de) * | 2002-11-13 | 2008-05-08 | Lts Lohmann Therapie-Systeme Ag | Mehrschichtiges transmucosales therapeutisches System |
JP2007517776A (ja) * | 2003-12-09 | 2007-07-05 | スフェリックス, インコーポレイテッド | カテコール官能基を有する生体接着性ポリマー |
EP1713450B1 (en) * | 2004-01-30 | 2021-10-06 | Corium, Inc. | Rapidly dissolving film for delivery of an active agent |
CA2518650A1 (en) * | 2004-09-10 | 2006-03-10 | Dimitrios Dimitrakoudis | Clostridium botulinum toxin formulation and method for reducing weight |
WO2007014003A2 (en) * | 2005-07-22 | 2007-02-01 | The Foundry Inc. | Systems and methods for delivery of a therapeutic agent |
US7655243B2 (en) * | 2005-07-22 | 2010-02-02 | The Foundry, Llc | Methods and systems for toxin delivery to the nasal cavity |
AU2012202088B2 (en) * | 2005-10-06 | 2015-01-15 | Allergan, Inc. | Non-protein stabilized clostridial toxin pharmaceutical compositions |
US8168206B1 (en) | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
KR101604515B1 (ko) | 2008-03-14 | 2016-03-17 | 알러간, 인코포레이티드 | 면역-기반 보툴리눔 독소 세로타입 a 활성 검정 |
CN105833254A (zh) * | 2008-12-10 | 2016-08-10 | 阿勒根公司 | 梭菌毒素药物组合物 |
SG174350A1 (en) | 2009-03-13 | 2011-10-28 | Allergan Inc | Cells useful for immuno-based botulinum toxin serotype a activity assays |
EP2731590B1 (en) | 2011-07-13 | 2018-05-23 | The Foundry, LLC | Methods and apparatus for delivering a therapeutic agent to nasopharyngeal mucosa targets |
US20140271867A1 (en) * | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Film delivery system for active ingredients |
EP2744482A4 (en) * | 2011-08-18 | 2015-03-11 | Monosol Rx Llc | STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARATION THEREOF |
US20140120077A1 (en) * | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and Methods for Safe Treatment of Rhinitis |
WO2015183044A1 (ko) * | 2014-05-29 | 2015-12-03 | 주식회사 프로셀테라퓨틱스 | 신규한 세포투과성 펩타이드 및 이와 보툴리눔 독소 결합체 및 이들의 용도 |
-
2018
- 2018-06-28 KR KR1020207002410A patent/KR20200024250A/ko not_active Application Discontinuation
- 2018-06-28 WO PCT/US2018/039964 patent/WO2019006098A1/en active Application Filing
- 2018-06-28 CA CA3066951A patent/CA3066951A1/en active Pending
- 2018-06-28 MX MX2019015451A patent/MX2019015451A/es unknown
- 2018-06-28 SG SG11201912890SA patent/SG11201912890SA/en unknown
- 2018-06-28 BR BR112019028080-4A patent/BR112019028080A2/pt not_active Application Discontinuation
- 2018-06-28 US US16/021,590 patent/US20190000935A1/en not_active Abandoned
- 2018-06-28 AU AU2018290925A patent/AU2018290925A1/en not_active Abandoned
- 2018-06-28 RU RU2020101929A patent/RU2020101929A/ru not_active Application Discontinuation
- 2018-06-28 EP EP18743268.7A patent/EP3644960A1/en not_active Withdrawn
- 2018-06-28 EP EP23179978.4A patent/EP4252779A3/en active Pending
- 2018-06-28 CN CN201880044149.6A patent/CN110913838A/zh active Pending
- 2018-06-28 JP JP2019572671A patent/JP2020526506A/ja active Pending
-
2019
- 2019-12-09 IL IL271278A patent/IL271278A/en unknown
- 2019-12-27 CL CL2019003873A patent/CL2019003873A1/es unknown
-
2021
- 2021-05-03 US US17/306,403 patent/US20220054605A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2019006098A1 (en) | 2019-01-03 |
RU2020101929A (ru) | 2021-07-30 |
KR20200024250A (ko) | 2020-03-06 |
CL2019003873A1 (es) | 2020-07-31 |
IL271278A (en) | 2020-01-30 |
EP4252779A3 (en) | 2023-10-25 |
MX2019015451A (es) | 2020-07-28 |
AU2018290925A1 (en) | 2020-01-16 |
EP4252779A2 (en) | 2023-10-04 |
US20220054605A1 (en) | 2022-02-24 |
CN110913838A (zh) | 2020-03-24 |
EP3644960A1 (en) | 2020-05-06 |
BR112019028080A2 (pt) | 2020-07-28 |
US20190000935A1 (en) | 2019-01-03 |
CA3066951A1 (en) | 2019-01-03 |
JP2020526506A (ja) | 2020-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245071A1 (zh) | 用於回腸-空腸給藥的組合物 | |
GB2536517B (en) | Opthalmic drug compositions | |
PL3105049T3 (pl) | Farmaceutyczna folia opakowaniowa przeciwdziałająca skalpowaniu | |
GB201706327D0 (en) | A pharmaceutical compound | |
EP3235736A4 (en) | Supply apparatus for drug packaging | |
EP3175326A4 (en) | Detector for a display | |
EP3235738A4 (en) | Cassette for drug packaging | |
SG10201502463TA (en) | A drug delivery composition | |
EP3334413A4 (en) | DISPENSER | |
PL3295906T3 (pl) | Układ do przeprowadzania fakoemulsyfikacji | |
EP3215102A4 (en) | Medicament dispenser | |
HUE046373T2 (hu) | Gyógyszercsomagolás | |
ZA201800586B (en) | A drug delivery device | |
ZA201605787B (en) | Formulations for small intestinal delivery | |
HK1244738A1 (zh) | 用於藥物輸送裝置的組件 | |
GB2528654B (en) | Drug dispenser assembly | |
IL271278A (en) | A soluble suppository for administration of a Clostridium derivative | |
ZA201808201B (en) | A plant-derived medicinal composition | |
EP3200803A4 (en) | Fungal glucosylceramide as a vaccine for fungal infections | |
EP3692997A4 (en) | DRUG FOR INFLUENZA | |
GB2558331B (en) | A banner | |
ZA201801904B (en) | A pharmaceutical composition | |
IL254200A0 (en) | A strange peptide as an anti-cancer agent | |
EP3562512A4 (en) | FORMULATION FOR THE STABILIZATION OF BIOTHERAPEUTICS | |
GB201706330D0 (en) | A pharmaceutical composition |